Across many species, a large fraction of genetic variants that influence phenotypes of interest is located outside of protein-coding genes, yet existing methods for identifying such variants have poor predictive power. Here, we introduce a new computational method, called LINSIGHT, that substantially improves the prediction of noncoding nucleotide sites at which mutations are likely to have deleterious fitness consequences, and which therefore are likely to be phenotypically important. LINSIGHT combines a simple neural network for functional genomic data with a probabilistic model of molecular evolution. The method is fast and highly scalable, enabling it to exploit the "Big Data" available in modern genomics. We show that LINSIGHT outperforms the best available methods in identifying human noncoding variants associated with inherited diseases. In addition, we apply LINSIGHT to an atlas of human enhancers and show that the fitness consequences at enhancers depend on cell-type, tissue specificity, and constraints at associated promoters.
Introduction
In the human genome, a large majority of nucleotides that are associated with diseases or other phenotypes, or that show signatures of natural selection, falls outside of protein-coding genes [1] [2] [3] .
Many of these nucleotides appear to fall in cis-regulatory elements, including promoters, enhancers, and insulators. Similar observations hold across most animals and plants, as well as some other eukaryotes [4] [5] [6] [7] . Nevertheless, the capability to identify and characterize functionally important noncoding sequences is decades behind that for protein-coding sequences. Investigators still lack a deep understanding of many fundamental properties of these sequences, including the manner in which they interact with chromatin and transcription factors and the biophysical dynamics of protein / nucleic acid complexes important in transcriptional and posttranscriptional regulation. This limited ability to make sense of noncoding DNA is a major barrier for progress in establishing the genetic basis for many diseases and other phenotypes, with major implications for biomedicine, agriculture, synthetic biology, and other fields.
For more than a decade, the genomics community has pushed for a deeper understanding of the noncoding genomes of many animal and plant species through systematic interrogation with high-throughput biochemical assays for features such as transcriptional activity, chromatin accessibility, and specific histone modifications and transcription factor binding events [8] [9] [10] [11] [12] . These efforts have produced a wealth of data for dozens of cell types across a range of organisms, and have helped both to identify many predicted regulatory elements, and to clarify many general aspects of gene regulation. Nevertheless, a substantial gap remains between the outcomes of these high-1 throughput experiments and a detailed understanding of noncoding function, for several reasons.
First, these assays generally measure genomic and epigenomic features roughly correlated with, but not directly indicative of, regulatory function. Second, they generally have relatively low resolution along the genome, identifying regions hundreds of nucleotides long, rather than pinpointing single nucleotides. Third, these measures are highly condition-specific, and data has only been generated for a small subset of cell types and conditions. As a consequence, there is a pressing need for computational methods that more precisely predict regulatory function by jointly considering the results of numerous such assays together with complementary data, such as annotations of protein-coding genes and measures of evolutionary conservation across species. The development of statistical and machine-learning methods that attempt to address this integrative prediction challenge has emerged as an active, fast-moving area of research. Recently published methods in this area can be roughly divided into three categories: (1) machine-learning classifiers that attempt to separate known disease variants from putatively benign variants using a variety of genomic features (e.g., GWAVA 13 and FATHMM-MKL 14 );
(2) sequence-and motif-based predictors for the impact of noncoding variants on cell-type-specific molecular phenotypes, such as chromatin accessibility or histone modifications (e.g., DeepBind 15 , DeepSEA 16 and Basset 17 ); and (3) evolutionary methods that consider data on genetic variation together with functional genomic data and aim to predict the effects of noncoding variants on fitness (e.g., CADD 18 , DANN 19 , FunSeq2 20 , and fitCons 3 ). A limitation of the first two classes of methods is that they depend strongly on the available training data, which may be limited and may not be representative of the broader class of regulatory sequences of interest. By contrast, the evolutionary methods obtain their signal not primarily from previously assigned class labels, but instead from signatures of natural selection across the genome over many generations, and they are therefore much less data limited. This approach is likely to be particularly powerful for regulatory sequences that tend to be under strong purifying selection, such as Mendelian disease variants. Evolution-based methods also naturally integrate over cell-types, an important strength when the relevant tissue-or cell-types for a condition of interest are unknown (as with many human diseases).
Among the available evolution-based methods, fitCons is unique in explicitly characterizing the influence of natural selection at each genomic site of interest using a full probabilistic evolutionary model and patterns of genetic variation within and between species. FitCons makes a distinction between functional genomic and comparative genomic data, first defining several hundred clusters of genomic positions with distinct functional genomic "signatures," and then estimating the fraction of nucleotides under natural selection within each cluster from polymorphism and divergence data. These estimates are obtained using the INSIGHT evolutionary model 21, 22 , and are interpreted as the probabilities that mutations in each cluster of genomic sites will have fitness consequences (fitCons scores). In this manner, fitCons aggregates information about natural selection from a large number of sites with similar functional profiles based on evolutionary first principles.
FitCons provides a useful, easily interpretable readout along the genome, complementary to conventional evolutionary conservation scores, and it performs well in predicting cell-type-specific functional elements. A major limitation of the method, however, is that it scales poorly with the available functional genomic data. In particular, the number of clusters considered by the method 3 increases exponentially with the number of functional genomic annotations. This exponential dependency limits the method's ability to take advantage of the growing body of available functional genomic data and therefore limits prediction power. A related problem is that the restriction to small numbers of genomic features leads to a relatively coarse-grained, blocky pattern of scores along the genome, which does not allow for fine distinctions among nearby nucleotide sites.
In this paper, we describe a new method, Linear INSIGHT (LINSIGHT; pronounced lin-site), that is based on the existing INSIGHT/fitCons framework but has vastly improved speed, scalability, genomic resolution, and prediction power. The main idea behind LINSIGHT is to bypass the clustering step of fitCons and instead couple the probabilistic INSIGHT model directly to a generalized linear model for genomic features. This results in a more streamlined model that scales linearly, rather than exponentially, with the available data, and can make direct use of the input data, with no need for discretization. This generalized linear model can be regarded as a simple neural network, and it readily extends to more complex, multi-layered networks, allowing for nonlinearities and interdendencies among genomic features. By integrating a large number of genomic features, LIN-SIGHT provides a systematic, high resolution description of the fitness consequences of noncoding mutations in the human genome. We demonstrate that LINSIGHT outperforms state-of-the-art prediction methods in the task of prioritizing noncoding disease variants from the Human Gene Mutation database (HGMD) 23 and the NCBI ClinVar database 24 . Furthermore, we use LINSIGHT to show that the evolutionary constraints on human enhancers depend on their associated tissue types, degree of tissue specificity, and associated promoters, which has important implications for understanding the evolution of cis-regulatory elements and for improving variant prioritization methods.
Our LINSIGHT scores are available as a track on the Cold Spring Harbor Laboratory mirror of the UCSC Genome Browser (hg19 assembly).
Results
LINSIGHT combines INSIGHT with a scalable linear model. The original INSIGHT and fitCons methods 3, 21, 22 infer the selective pressure on noncoding sites, and hence the likely fitness consequences of noncoding mutations, by contrasting patterns of genetic variation at each focal site with the patterns at nearby genomic regions that are likely to be free from the influence of selection ("neutrally evolving sites"). To address the problem that genetic variation within species and between closely related species (such as the human and chimpanzee) are sparse across the genome, fitCons pools information across the thousands of genomic sites assigned to each discrete cluster.
The key idea behind LINSIGHT is instead to accomplish this pooling of information across sites indirectly, using a generalized linear model ( Figure 1 ; see Supplementary Text and Supplementary Table 1 for complete details). In particular, the parameters of the INSIGHT model that describe natural selection (ρ and γ) are determined as linear-sigmoid functions of the genomic features local to each site. Thus, the fitness consequences of mutations at each site are assumed to depend on genomic features at that site, such as its RNA expression level (RNA-seq read depth), chromatin accessibility (DNase-I hypersensitive sites), histone modifications or bound transcription factors (ChIP-seq peaks), as well as features based on annotations (e.g., distance to nearest transcription start site, match to known TFBS motif) and comparative genomics (e.g., phyloP or phastCons scores). This approach has several major advantages: it requires no clustering and no discretization a priori, and it scales linearly with the available genomic features, allowing hundreds or even thousands of features to be considered. In contrast to fitCons, the scalability of the method enables data to be pooled across cell-types, and it allows the scores to reach single-nucleotide resolution along the genome. Nevertheless, LINSIGHT continues to benefit from the advantages of the probabilistic INSIGHT model of molecular evolution.
All parameters of the LINSIGHT model can be estimated simultaneously from genome-wide data by maximum likelihood using an online stochastic gradient descent algorithm (Methods).
The gradients for the feature weights can be efficiently computed by the back-propagation method widely used in neural network training 25 . Indeed, the model can be considered a type of neural network, albeit one without hidden layers. Its main disadvantage relative to fitCons-the assumption of an additive, linear relationship between features and selection parameters-could be addressed by adding hidden layers to the neural network, although we have found its performance to be excellent without this extension. Notably, the amount of data available for training is large in comparison to the number of free parameters and we have not found regularization to be necessary, but it could easily be added if necessary.
LINSIGHT scores across the human genome are generally consistent with, but often improve on, previous measures of evolutionary conservation. We applied LINSIGHT to a large public data set consisting of complete genome sequences for multiple human individuals and nonhuman primates, comparative genomic data for mammals and vertebrates, and a wide variety of functional genomic data, and we generated LINSIGHT scores for all positions across human reference genome (Methods). We considered a total of 48 genomic features, falling in three general classes: 6 conservation scores, predicted binding sites, and regional annotations (Table 1 and Supplementary   Table 2 ). We used the human polymorphism data (from the Complete Genomics "69 Genomes" data set) and primate divergence data (from alignments of the human, chimpanzee, orangutan, and rhesus macaque genomes) that were used for fitCons 3 . Note that, while it might appear circular to use evolutionary conservation scores as features since LINSIGHT's objective function is also essentially a measure of conservation, these scores reflect the influence of natural selection over alternative time scales (e.g., ∼80 million years of mammalian evolution), and considering them in this way substantially improves prediction performance (as shown below; see Discussion).
The distributions of INSIGHT scores in annotated regions of the noncoding genome are generally consistent with previous observations based on conservation scores 1, 4, 26 . For example, splice sites are very highly constrained (median LINSIGHT score of 0.956, indicating a 95.6% probability of fitness consequences due to mutations at these nucleotide sites), whereas annotated TFBSs show reduced, but still substantial, constraint (median score of 0.240 for TFBSs shared across species, median score of 0.106 for all TFBSs from the Ensembl Regulatory Build 27 ; Figure 2a ). Other promoter regions (median score of 0.073) and untranslated regions (UTRs; median scores of 0.128 and 0.076 for 5 and 3 UTRs, respectively) are somewhat less constrained, and unannotated intronic and intergenic regions exhibit the least constraint (median scores of 0.044-0.048). As observed previously, 5 UTRs show somewhat more constraint than 3 UTRs, although both types of UTRs contain subsets of sites subject to strong selection (LINSIGHT score >0.8) 4, 26 . The estimate for the more conserved TFBSs (0.240) is roughly similar to, if slightly lower than, previous estimates directly obtained from experimentally defined TFBSs (∼30-40% of sites under selection 22, 28 ), de-spite that it was obtained indirectly in this case via the generalized linear model. The genome-wide average of the LINSIGHT scores is about 0.07, suggesting that about 7% of noncoding sites are under evolutionary constraint, consistent with numerous previous studies 3, 4, [29] [30] [31] .
Across all noncoding positions in the genome, the LINSIGHT scores are fairly well correlated with scores from recently published methods such as FunSeq2 20 and Eigen 32 (Spearman's ρ = 0.43-0.48), moderately with those from fitCons 3 (ρ = 0.33), and relatively poorly with those from phyloP 26 , GERP++ 33 , and CADD 18 (ρ = 0.04-0.06; Supplementary Figure 1a ). However, these sitewise correlations are strongly influenced by large regions of the genome bereft of functional genomic data. Within phastCons-predicted conserved elements 4 , which are strongly enriched for regulatory function, LINSIGHT's correlation increases to ρ = 0.62-0.66 for phyloP, GERP++, and Eigen, and to ρ = 0.43 for CADD, while decreasing to ρ = 0.42 for FunSeq2 and to ρ = 0.16 for fitCons ( Supplementary Figure 1b) . In general, the scores that make use of functional genomic data, including those from LINSIGHT, FunSeq2, Eigen, and CADD, are relatively well correlated, as are those from the pure conservation methods, phyloP and GERP++, but these two groups of scores are less well correlated with one another. The fitCons method shows the least correlation with other methods, primarily because of its low genomic resolution.
On the task of identifying likely regulatory elements in unannotated regions of the genome, the functional genomic methods generally perform better than pure conservation methods, and LINSIGHT is among the best available methods at this task. For example, LINSIGHT has good power to identify transcription factor binding sites from the ORegAnno database 34 , with an AUC = 0.926, outperformed only by DeepSEA (AUC = 0.965) and FunSeq2 (AUC = 0.950) among seven meth-ods tested (Supplementary Figure 2 ). These three methods perform substantially better than conservation-based methods (e.g., phyloP has AUC = 0.884) as well as methods that use functional genomic data such as GWAVA (AUC = 0.814), CADD (AUC = 0.841), and Eigen (AUC = 0.899).
Thus, despite that it relies on an evolutionary objective function, LINSIGHT maintains good performance in the prediction of regulatory elements, competitive with methods optimized for regulatory element prediction and superior to methods that consider evolutionary conservation alone.
Consistent with these general trends, LINSIGHT highlights many of the regions identified by conservation-methods such as phastCons, phyloP, and GERP++, but also identifies some regions that have relatively low conservation scores yet are likely to have important biological func-
tions. An example is HGMD variant CR065653, associated with up-regulation of the telomerase reverse transcriptase (TERT) gene, which obtains an elevated LINSIGHT score, but is not identified by phastCons, phyloP, or GERP++ as being under constraint ( Figure 2b ). This example also demonstrates that the genomic resolution of the LINSIGHT scores is dramatically better than that of fitCons, and approaches the nucleotide resolution of phyloP and GERP++.
LINSIGHT accurately identifies disease-associated variants in noncoding regions. We tested the ability of LINSIGHT to identify noncoding nucleotide positions that are associated with inherited human diseases, using the HGMD 23 and ClinVar 24 databases to define positive examples, and common polymorphisms (MAF > 1%), which are unlikely to be functionally important, to define negative examples. For comparison, we evaluated the CADD 18 , Eigen 32 , DeepSEA 16 , FunSeq2 20 , GWAVA 13 , and phyloP 26 methods on the same task. For each scoring method, we computed false positive vs. true positive rates for the complete range of score thresholds, displaying the results as Overall, LINSIGHT outperformed all other methods in all comparisons (Figure 3 and Supplementary Figure 3 ). Its absolute prediction power varied across matching schemes in a predictable manner, being highest in the unmatched comparison (e.g., AUC = 0.897 for HGMD) and decreasing in the matched TSS (AUC = 0.759) and matched region (AUC = 0.660) comparisons.
The same effect also occurred for most other methods, but the methods that make heavier use of regional information, such as FunSeq2, suffered more as the matching stringency increased. In almost all cases, the AUCs were considerably higher for ClinVar than for HGMD, apparently because ClinVar is heavily enriched for variants in splice sites, which are relatively easy to identify (Supplementary Figure 4 ). An exception to this rule was GWAVA, which performs exceptionally well on HGMD (cross-validation AUCs of 0.71-0.97) 13 and much more poorly on ClinVar (AUCs of 0.741-0.887), but GWAVA was trained using HGMD 13 and its performance on that data set appears to reflect overfitting (not shown in the ROC plots for this reason). This dependency on the training set for GWAVA demonstrates one of the pitfalls of pure classification strategies, and highlights a strength of the evolution-based strategy, which are much less dependent on a training set. Nevertheless, phyloP performs quite poorly on the HGMD data set, and CADD is only slightly better, showing that scores based exclusively or primarily on evolution are of limited usefulness in this task. The excellent performance of INSIGHT in the tests appears to derive from its use of both a broad collection of informative features along the genome and an evolution-based objective function.
The relative contributions of genomic features to LINSIGHT prediction performance are context-dependent. The genomic features used by LINSIGHT can be grouped into three broad classes: conservation scores, predicted binding sites, and regional annotations ( Table 1 ). We examined the relative contributions to prediction power of these feature classes by retraining the model three times, each time removing a different class of features. This procedure was applied at the level of feature classes, rather than individual features, because of the strong correlations among the features within each class. We measured the prediction power of each version of the model using the AUC statistic, as above, but this time we merged the HGMD and ClinVar variants and then divided them into four categories based on their locations relative to genomic annotations: variants in promoters of protein coding genes; variants in 5 or 3 UTRs; variants proximal to splice sites; and all other noncoding variants. As a measure of the contribution of each class of features, we used the reduction in AUC resulting from the exclusion of that feature class. Thus, a large reduction in AUC implies that the removed features are highly important in prediction, while a small reduction implies that they are less important. The evolutionary constraints on enhancers are context-dependent. In addition to its value in identifying regulatory sequences and predicting disease relevance, LINSIGHT is potentially useful for studying the influence of natural selection on noncoding sequences. Compared with other measures of selection, LINSIGHT has the advantages of considering both functional genomic and population genomic data, of detecting the influence of selection on relatively recent time scales (e.g., since the human/chimpanzee divergence), and of providing a model-based, easily interpretable measure of fitness consequences. With these advantages in mind, we used the method to gauge the degree of evolutionary constraint on enhancers in the human genome, considering in particular the relationships between constraint and the number and type of active cell types and the target promoter of each enhancer. We analyzed nearly 30,000 enhancers (median length 293 bp) from a recently published atlas of active enhancers in dozens of human cell types and tissues, which were identified based on their transcriptional signatures 35 . This approach of annotating enhancers based on enhancer-associated RNAs (eRNAs) has been shown to identify elements having active roles in gene regulation in a cell-type-specific fashion with high genomic resolution [35] [36] [37] .
First, we examined the relationship between the LINSIGHT scores and the number of cell types in which each enhancer is active. We found that the LINSIGHT scores were significantly positively correlated with the number of active cell types (p < 10 −15 ; Figure 5a ), indicating that a broader spectrum of activity across cell types is associated with stronger purifying selection. This finding parallels similar findings for protein-coding genes [38] [39] [40] and TFBSs 22 and likely reflects a general correlation between pleiotropy and constraint (see Discussion). Second, we examined the relationship between the LINSIGHT score for each enhancer and the tissue type in which that enhancer is active, focusing on tissue-specific enhancers (active in a single tissue type). We found that tissue-specific enhancers that were associated with sensory perception (olfactory region and parotid gland), the immune system (lymph node), digestion (stomach), and male reproduction (penis and testis) had the lowest LINSIGHT scores, whereas tissue-specific enhancers associated with tissues such as smooth muscle, the skin, and the urinary tract and bladder had the highest LIN-SIGHT scores (Supplementary Figure 6 ). These findings are also broadly consistent with findings for protein-coding genes, which have indicated that sensory, immune, dietary, and male reproduc-13 tive genes are enriched with positively selected (fast evolving) genes 40, 41 . Interestingly, enhancers active in tissues associated with female reproduction (e.g., uterus, female gonad, and vagina) appeared to be under substantially more constraint than those active in tissues associated with male reproduction, perhaps owing to increased positive selection on male reproductive functions. Finally, we compared the LINSIGHT scores at enhancer/promoter pairs predicted from co-expression across tissues 35 . The LINSIGHT scores for these paired enhancers and promoters are weakly but significantly correlated (Figure 5b) , indicating that the same types of evolutionary pressures tend to act at both members of each pair. Together, these results indicate that the evolutionary constraints on enhancers are dependent on several factors, including their degree of tissue specificity, the particular tissues in which they are active, and the evolutionary constraints associated with their target promoters.
Discussion
As sequencing costs fall and appreciation for regulatory variation grows, whole genome sequencing is rapidly supplanting exome sequencing as the primary technique for identifying and characterizing genetic variants that have phenotypic consequences. Hence, there is an increasing need for computational methods that can effectively prioritize noncoding variants based on their likelihood of phenotypic importance. In this paper, we address this problem with a new computational method, called LINSIGHT, that combines the evolutionary model of our previously developed IN-SIGHT method with a generalized linear model for functional genomic data and genome annotations, resulting in substantially improved scalability, resolution, and power. We have generated 14 LINSIGHT scores across the human genome, making use of a large collection of publicly available population, comparative, and functional genomic data, and we find the scores to be consistent with previously available scoring in many respects, but to improve on them in others. For example, they have better power than both pure conservation-based methods and methods based on genomic polymorphism for identifying known transcription factor binding sites. They are competitive with modern machine-learning methods, such as DeepSEA 16 , that are specifically designed for binding site identification. On the task of identifying human disease-associated variants from the HGMD and ClinVar databases, LINSIGHT offered the best performance of several methods we tested, across a range of types of variants and test designs. Importantly, LINSIGHT requires no training set of known regulatory or disease variants and therefore is expected to have better generalization properties and fewer biases than "supervised" machine-learning classifiers or sequenceand motif-based predictors (see Introduction). This improved generalization was evident in the improved performance of LINSIGHT across tests sets compared with GWAVA.
In conceptual terms, the new LINSIGHT method is closely related to our previous fitCons method 3 , with the primary difference being that LINSIGHT pools data across sites implicitly through the use of its linear-sigmoid model, whereas fitCons pools data by explicitly clustering sites according to discretized functional genomic signatures. In effect, LINSIGHT trades the restrictions of a linearity assumption for the benefits of computational speed, a reduced parameterization, and scalability to very large numbers of genomic features. Notably, the new model design also has a number of important side benefits. First, it avoids the need for discretization of the genomic features. In addition, as the number of features grows larger, the genomic resolution of the scores naturally becomes much finer, approaching the nucleotide-level resolution of conservation scores.
Finally, the linear-sigmoid model can naturally be extended to a "deep" neural network through the addition of hidden layers. While it remains to be seen how much this extension will help in practice, in principle it can address the types of nonlinearity and interactions between features that have been observed in this setting (for examples, see references [3] and [42] ), and it may therefore improve estimates of the fitness consequences of noncoding mutations.
Our approach to characterizing noncoding variants is based on the premise that natural selection in the past, at individual nucleotide sites, provides useful information about phenotypic importance in the present. This assumption clearly will not hold in all cases. For example, variants that increase the risk for post-reproductive diseases or that influence phenotypes dependent on features of the modern environment (such as smoking, industrial chemicals, or abundant highcalorie food) will not necessarily show signs of historical purifying selection. In addition, traits dependent on highly epistatic loci or on the aggregate contributions of large numbers of loci may have difficult-to-detect marginal contributions to fitness at individual nucleotides. Nevertheless, our results indicate that the evolution-based approach is useful for many phenotypes of interest.
Furthermore, it is important to bear in mind that experimental approaches for identifying gene regulatory mutations also have limitations. For example, methods that depend on reporter gene assays may not adequately consider the true genomic context and cell-type-dependence of a mutation, and methods that depend on an RNA expression readout may not consider post-transcriptional or post-translational influences. Evolution-based methods have the important advantage of measuring the importance of genetic variants in real organisms in their natural environments over many generations. Thus, we expect that these methods will remain a powerful, complementary tool for characterizing regulatory sequences, even as experimental methods improve.
In our previous work, we avoided considering evolutionary conservation as a genomic feature, instead making a clear distinction between features based on functional genomics and an objective function based on patterns of genetic variation (via INSIGHT) 3 . In this work, we found that we could improve our prediction performance substantially by relaxing this distinction and including conservation scores as inputs to the model (see also references [13, 16, 18] ). Thus, despite the limitations of conventional conservation scores-such as their sensitivity to alignment error and evolutionary turnover-they appear to be among the most informative features about the recent natural selection measured by the INSIGHT model. We attribute their value in this setting to the freedom of LINSIGHT to find a weighted combination of conservation scores, functional genomic data, and annotations that is most informative about recent selection. The value of conservation scores may increase further in an extension to a deep neural network, because conservation is likely to be more informative in the presence of some combinations of genomic features than others. For example, evolutionary conservation on the timescale of mammalian evolution is likely to be more informative about recent selection in protein-coding genes, promoters, and splice sites than in enhancers, which exhibit more turnover 43 .
Using LINSIGHT, we examined the influence of negative selection on enhancers, considering the relationships between constraint on enhancers and numbers of active cell types, tissue of activity, and constraint at associated promoters. LINSIGHT is potentially useful for addressing these questions because it should be much more robust to evolutionary turnover than conven-tional conservation-based methods, and some classes of enhancers are known to turn over more quickly than others 43 . We found that, in general, the trends in constraint at enhancers parallel those previously reported for protein-coding genes. For example, constraint increases with breadth of activity across cell types and decreases in tissues associated with adaptation, such as olfactory regions, the immune system, and male reproduction. Constraint also appears to be correlated at enhancer/promoter pairs. These observations about the specific ways in which evolutionary constraints on enhancers depend on genomic context may be useful in improving the prediction power for the fitness consequences of noncoding mutations.
As has been suggested for protein-coding genes 38 , it seems plausible that the positive correlation between the strength of constraint and the number of active cell types can be explained by pleiotropy: enhancers active in more cell types are more likely to participate in multiple regulatory networks, perhaps with distinct roles involving the binding of different factors and/or the use of different binding sites within each enhancer. As a result, they may be subject to greater constraint.
Notably, some of the other explanations offered for a similar correlation between breadth of expression and constraint in protein-coding genes-such as selection for translational efficiency 44, 45 or against misfolding 39 Online Methods Genomic features. The genomic features used by LINSIGHT can be divided into three categories: conservation scores, predicted binding sites, and regional annotations ( Table 1 and Supplementary Table 2 ). Conservation scores included phyloP scores 26 , phastCons elements 4 , SiPhy omega elements 50, 51 , and CEGA elements 52 . Except for SiPhy, each score type was represented by multiple data tracks-for example, phastCons tracks for vertebrate, mammalian, and primate alignments (Supplementary Table 2 ). Predicted binding sites included transcription factor binding sites (TFBS) and RNA binding sites. Predicted TFBSs were obtained from the conserved TFBS track in the UCSC Genome Browser 53 , the rVISTA database 54 , SwissRegulon 55 , FunSeq2 20 , and the Ensembl Regulatory Build 27 . RNA binding sites include splice sites predicted by SPIDEX 56 and miRNA target sites predicted by TarBase 57 . The regional annotations were based a variety of sources, including ChIP-seq and RNA-seq data from the ENCODE 11 and Roadmap Epigenomics 12 projects, enhancers from FANTOM5 58 , predicted distal regulatory modules from FunSeq2 20 , and the distances to nearest TSSs based on GENCODE gene models 59 . All features and the resulting LINSIGHT scores were expressed in genomic coordinates for the hg19 assembly of the human genome.
Polymorphism and divergence data. The polymorphism and divergence data used by the IN-SIGHT component of the LINSIGHT model were borrowed from previous analyses 3, 21, 22 . Briefly, we obtained human single nucleotide polymorphisms from high-coverage genome sequences for 54 unrelated individuals from the "69 Genomes" dataset from Complete Genomics, eliminating 20 nucleotide sites with more than two alleles. Outgroup alleles were defined by the aligned chimpanzee, orangutan, and rhesus macaque reference genomes from UCSC. Several filters were applied to these data to reduce technical errors from alignment, sequencing, and genotype inference; Fitting the LINSIGHT model to the data. The weights for all genomic features were estimated by approximately maximizing the log likelihood of the INSIGHT model with respect to our genomewide data set. We began by considering all genomic positions not excluded by our data-quality filters. Because our focus was on noncoding regions, we additionally excluded coding regions annotated by GENCODE (release 19). Instead of a traditional "batch" learning algorithm, which would require either storing all data in memory or reading it from disk many times, we used an "online" stochastic gradient descent algorithm 60 . The algorithm processed the genome in "minibatches" of Comparison with other methods. Our benchmarking scheme for prioritization of disease-associated variants closely followed the one introduced in ref. [13] . The HGMD and ClinVar noncoding disease variants and three sets of negative controls were obtained from this study. The negative controls consisted of: (1) a randomly selected subset of human common variants (unmatched);
(2) a subset of human common variants matched to the disease variants by distance-to-nearest-TSS (matched TSS); and (3) a subset of human common variants required to be in the same local genomic region as the matched disease variants (matched region). The two matched sets account for the enrichment of known disease variants near coding genes. For comparison, we downloaded precomputed CADD 18 (v1.3), GWAVA 13 (v1.0), FunSeq2 20 (v2.1.0), and Eigen 32 (Oct. 11, 2015) scores from the source websites. GWAVA scores based on training with variants matched by distance-to-nearest-TSS were used in all comparisons 13 . In addition, we obtained mammalian phyloP 26 scores based on the 46-way whole-genome alignment for hg19 from the UCSC Genome Browser 53 . The DeepSEA scores of the disease variants and their negative controls were computed using the online DeepSEA web service 16 on Jan 14, 2015. Note that two of the methods considered, CADD and DeepSEA, provide allele-specific predictions, whereas the other methods assign identical scores to all alternative variants. When evaluating CADD and DeepSea on the ClinVar data set, we used the score corresponding to the annotated disease-associated allele. When eval-uating these methods on the HGMD data set, however, no disease-associated allele was provided, so we used the maximum score for the three alternative alleles.
Classification of disease-associated variants by genomic location. For analyses that considered the genomic locations of disease-associated variants, we divided the variants in the HGMD and ClinVar databases into four categories based on their locations relative to gene models from GEN-CODE (release 19). These categories were: (1) "promoter" variants, located within 1 kb upstream of the 5 -most annotated transcription start site of any protein-coding gene; (2) "splicing" variants, located within 20 bp of any annotated splice junction; (3) "UTR" variants, located within the annotated 5 or 3 UTR of any protein-coding gene; and (4) all "other" variants. Each variant was assigned to the first category whose criteria it fulfilled in the order splicing > UTR > promoter > other.
Quantification of the contributions of genomic feature classes. We measured the relative contributions of the conservation scores, predicted binding sites, and regional annotations by removing all features of each class (see Table 1 ), retraining the LINSIGHT model without those features, and evaluating the AUC of the reduced model. The contribution of each class of features was defined as the AUC for the full model minus the AUC for the reduced model. Notice that, while this difference in AUCs is generally positive, it may be negative due to stochastic effects. This analysis was performed on a merged set of HGMD and ClinVar variants, separately for each of the four genomic location labels defined above.
Analysis of evolutionary constraints on enhancers.
To study evolutionary constraints on enhancers, we used the comprehensive atlas of human enhancers across cell types based on enhancer RNAs (eRNAs) that was recently provided by the FANTOM5 project 58 . The evolutionary constraint for each enhancer was quantified by taking the average LINSIGHT score across all nucleotide sites in the enhancer. We examined the relationship between this measure of constraint and the number of cell types in which each enhancer was active (according to a detectable eRNA signature). We also defined a subset of enhancers as tissue-specific, based on apparent activity in only a single tissue type, and examined the relationship between tissue of activity and degree LINSIGHT is able to distinguish among these three modes of evolution because they have different effects on divergence and polymorphism patterns. In particular, as in INSIGHT, we assume that mutations in strongly negatively selected sites are immediately removed from the population and cannot segregate or fix in the human population. In addition, we assume that mutations in weakly negatively selected sites can segregate at low frequencies but cannot reach high frequencies or fix in the human population. In contrast, mutations in neutral sites can segregate at both low and high frequencies and can fix in the human population.
Polymorphism and divergence data. LINSIGHT gains power by combining the signatures of natural selection from both polymorphisms within the target species and divergences between species. The parameter ρ i is the main focus of our analysis. This parameter can be interpreted as the probability that a mutation at that site will have fitness consequences. Nucleotide-specific estimates of this parameter are therefore referred to as fitness-consequence scores, or simply, as LINSIGHT scores. The parameter γ i is influenced by both weak and strong selection and is more difficult to interpret. This parameter is used for fitting the model but is ignored in our subsequent analyses.
As in INSIGHT
Note that the definition of γ i here is slightly different from its definition in the INSIGHT model (denoted here by γ i ), which was defined as the relative rate of polymorphisms. There is a simple linear relationship between γ i and γ i : γ i = β 1 γ i . This redefinition of γ i was needed to ensure that its range would match that of the sigmoid function (0, 1).
Because the information about natural selection at each individual nucleotide is very limited, some means for pooling statistical information across sites is needed. In LINSIGHT, this pooling is achieved by a generalized linear regression model. We assume that the selection parameters at each focal site can be predicted by a linear function of local genomic features, together with a nonlinear "link" function. Specifically, if D i is a column vector of genomic features associated with site i, LINSIGHT assumes that,
where the row vectors W ρ and W γ represent the weights of genomic features with respect to ρ and γ, respectively, and g() and h() are nonlinear link functions. Following the common practice in machine learning, we assume that the first element of D i is always equal to 1 and the corresponding weights in W ρ and W γ represent the intercepts for the respective linear functions. For the link functions g() and h(), we use two sigmoid functions,
where g(x) is known as the Gompertz sigmoid function 4 
Here, P (S i |W ρ , D i ) represents the prior probability that site i is under selection conditional on genomic features D i and weights W ρ . Based on equation 1, this prior probability is given by
The other probability in equation 3, 
represents the generation of fixed mutations (substitutions) along the human lineage, and P (X i |
represents the generation of polymorphisms in the human population. As in
modeled by an approximate Jukes-Cantor substitution model 5, 6 . Here,
where t represents the evolutionary time between the human-chimpanzee MRCA and the human population MRCA. Note that, unlike in INSIGHT, when site i is under selection, no substitution is possible because positive selection is prohibited in LINSIGHT. As in INSIGHT, however, recurrent substitutions at the same site are ignored due to the very short divergence time between human and chimpanzee.
The final term in equation 4, P (X i |S i , A i , W γ , D i , ζ i ), represents the generation of (unfixed) polymorphisms in the human population. As in INSIGHT, we assume a simple infinite-sites model for the generation of polymorphisms, in which polymorphisms are generated at rate θ i (and all three alternative alleles are equally likely), and the allele frequency category (L or H) is determined by the β and γ i parameters. Specifically, we assume:
where n is the number of haploid genomes sampled at site i, a n = n−1 k=1 1 k is Watterson's constant 7 , and γ i is given by equation 1. As in INSIGHT, Watterson's constant a n can be used to accommodate small amounts of missing data 1 . Notice in equation 6 that polymorphisms in sites under selection (S i = sel) are only permitted to segregate at low frequencies, consistent with the assumptions of the model. Combining equations 5 and 6 and then summing over possible values of A i , we obtain the conditional likelihood P (X i |S i , Z i , W γ , D i , ζ i ), which is summarized in Table 1 . Finally, the full likelihood (equation 3) is calculated by summing over possible values of Z i . Table 1 :
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represents the set of neutral parameters associated with site i. b γ i = h(W γ D i ) represents the relative rate of low-frequency derived alleles. . We considered all TFBSs in the ORegAnno database 8 that were associated with the hg19 assembly, merging overlapping binding sites (7, 369 TFBSs in total). 

